Results 241 to 250 of about 527,738 (310)

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Gait impairment is a distinctive symptom of Parkinson's disease that negatively impact mobility. We assessed the validity of wearable digital insoles against a validated reference gait analysis system for measuring select gait characteristics in patients with Parkinson's disease. Methods A comparative analysis between digital insoles
Deborah A. Hall, Kimberly Kwei, Rolando J. Acosta, Bharatkumar Koyani, Erin Robertson, Pratyush Rai, Roland Barge, Emily Timm, Nicollette L. Purcell, Natasha Desai, Dhanesh Patel, Ana‐Maria Visoiu‐Knapp, Samuel Stuart, Rinol Alaj, Matthew F. Wipperman, Oren Levy, Joan A. O'Keefe   +16 more
wiley   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina, Anna Marcé‐Grau, Barbara Masotto, Marta Codina, Lamia BenJemaa, Yasmina Elaribi, Mónica Martinez‐Gallo, Roger Colobran, Angel Sanchez‐Montañez, Irene Valenzuela, Yoshiko Murakami, Alfons Macaya   +11 more
wiley   +1 more source

Predictive Value of Inflammatory Markers NLR, PLR, APRI, SII, and Liver Function Tests in Systemic Inflammatory Response Syndrome Detection in Full-Term Newborns. [PDF]

Children (Basel)
Pantea M, Iacob D, Dima M, Prodan M, Belei O, Negrean RA, Ilie AC.   +6 more
europepmc   +1 more source

Effects of Portulaca oleracea (purslane) on liver function tests, metabolic profile, oxidative stress and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized, double-blind clinical trial. [PDF]

Front Nutr
Milkarizi N, Barghchi H, Belyani S, Bahari H, Rajabzade F, Ostad AN, Goshayeshi L, Nematy M, Askari VR.   +8 more
europepmc   +1 more source

The relation between serum ferritin level and liver function tests in liver diseases

The Turkish Journal of Gastroenterology, 1995
Orhan SEZGİN, Kazım SOYLU, Özden UZUNALİMOĞLU   +2 more
doaj  

[LIVER FUNCTION TESTS].

Srpski arhiv za celokupno lekarstvo, 1996
S, STEFANOVIC, P, TRAJKOVIC
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Liver Function Tests

CRC Critical Reviews in Clinical Laboratory Sciences, 1971
(1971). Liver Function Tests. CRC Critical Reviews in Clinical Laboratory Sciences: Vol. 2, No. 4, pp. 573-599.
Kerry J. Breen, Steven Schenker, Leon Schiff   +2 more
openaire   +2 more sources